Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Halfpenny

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Neurorx : the Journal of the American Society for Experimental Neurotherapeutics|February 18, 2005
Cell therapy in demyelinating diseasesClaire Rice, Christopher Halfpenny, Neil Scolding
The Lancet. Neurology|July 10, 2003
Cell transplantation, myelin repair, and multiple sclerosisChristopher Halfpenny, Tracey Benn, Neil Scolding
Multiple Sclerosis and Related Disorders|May 31, 2016
Neuromyelitis optica relapses: Race and rate, immunosuppression and impairmentGeorge Tackley, Fanny O'Brien, João Rocha, et al.
Neurology|December 12, 2024
Quantitative Contribution of Clinical Attacks to Residual Disability in Patients With AQP4-Antibody Neuromyelitis Optica Spectrum DisorderBo Chen, Anna Francis, Sarah A Cooper, et al.
Brain : a Journal of Neurology|February 4, 2026
Optimal strategies for treatment discontinuation in MOG antibody-associated diseaseWei Z Yeh, Anna Francis, Sarah Cooper, et al.
Multiple Sclerosis and Related Disorders|March 29, 2024
A study of referral bias in NMOSD and MOGAD cohortsMiguel Leal Rato, Bo Chen, Anna Francis, et al.
JAMA Network Open|January 10, 2022
Factors Associated With Relapse and Treatment of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease in the United KingdomChanjira Satukijchai, Romina Mariano, Silvia Messina, et al.
Annals of Neurology|July 3, 2023
Do Early Relapses Predict the Risk of Long-Term Relapsing Disease in an Adult and Paediatric Cohort with MOGAD?Bo Chen, Enrique Gomez-Figueroa, Vyanka Redenbaugh, et al.
Nature Genetics|October 1, 2013
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis, Ashley H Beecham, Nikolaos A Patsopoulos, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Neurorx : the Journal of the American Society for Experimental Neurotherapeutics|February 18, 2005
Cell therapy in demyelinating diseasesClaire Rice, Christopher Halfpenny, Neil Scolding
The Lancet. Neurology|July 10, 2003
Cell transplantation, myelin repair, and multiple sclerosisChristopher Halfpenny, Tracey Benn, Neil Scolding
Multiple Sclerosis and Related Disorders|May 31, 2016
Neuromyelitis optica relapses: Race and rate, immunosuppression and impairmentGeorge Tackley, Fanny O'Brien, João Rocha, et al.
Neurology|December 12, 2024
Quantitative Contribution of Clinical Attacks to Residual Disability in Patients With AQP4-Antibody Neuromyelitis Optica Spectrum DisorderBo Chen, Anna Francis, Sarah A Cooper, et al.
Brain : a Journal of Neurology|February 4, 2026
Optimal strategies for treatment discontinuation in MOG antibody-associated diseaseWei Z Yeh, Anna Francis, Sarah Cooper, et al.
Multiple Sclerosis and Related Disorders|March 29, 2024
A study of referral bias in NMOSD and MOGAD cohortsMiguel Leal Rato, Bo Chen, Anna Francis, et al.
JAMA Network Open|January 10, 2022
Factors Associated With Relapse and Treatment of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease in the United KingdomChanjira Satukijchai, Romina Mariano, Silvia Messina, et al.
Annals of Neurology|July 3, 2023
Do Early Relapses Predict the Risk of Long-Term Relapsing Disease in an Adult and Paediatric Cohort with MOGAD?Bo Chen, Enrique Gomez-Figueroa, Vyanka Redenbaugh, et al.
Nature Genetics|October 1, 2013
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis, Ashley H Beecham, Nikolaos A Patsopoulos, et al.
Pageof 1